Quadrant Capital Group’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3
| Closed | – | – | 2652 |
|
|
2021
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 2502 |
|
|
2020
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 2418 |
|
|
2020
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 2375 |
|
|
2020
Q2 | $0 | Sell |
3
-93
| -97% | -$3.47K | ﹤0.01% | 2496 |
|
|
2020
Q1 | $4K | Sell |
96
-570
| -86% | -$32.4K | ﹤0.01% | 1740 |
|
|
2019
Q4 | $42K | Hold |
666
| – | – | 0.01% | 1427 |
|
|
2019
Q3 | $44K | Hold |
666
| – | – | 0.01% | 1279 |
|
|
2019
Q2 | $50K | Buy |
666
+525
| +372% | +$36.9K | 0.01% | 1224 |
|
|
2019
Q1 | $5K | Sell |
141
-27
| -16% | -$2.04K | ﹤0.01% | 1891 |
|
|
2018
Q4 | $7K | Hold |
168
| – | – | ﹤0.01% | 1539 |
|
|
2018
Q3 | $11K | Hold |
168
| – | – | ﹤0.01% | 1261 |
|
|
2018
Q2 | $11K | Sell |
168
-46
| -21% | -$5.14K | ﹤0.01% | 1234 |
|
|
2018
Q1 | $19K | Buy |
214
+144
| +206% | +$16.1K | 0.01% | 983 |
|
|
2017
Q4 | $5K | Hold |
70
| – | – | ﹤0.01% | 1499 |
|
|
2017
Q3 | $5K | Buy |
70
+24
| +52% | +$1.89K | ﹤0.01% | 1496 |
|
|
2017
Q2 | $2K | Hold |
46
| – | – | ﹤0.01% | 1644 |
|
|
2017
Q1 | $3K | Hold |
46
| – | – | ﹤0.01% | 1532 |
|
|
2016
Q4 | $3K | Hold |
46
| – | – | ﹤0.01% | 1417 |
|
|
2016
Q3 | $3K | Hold |
46
| – | – | ﹤0.01% | 1411 |
|
|
2016
Q2 | $2K | Buy |
46
+18
| +64% | +$1.24K | ﹤0.01% | 1507 |
|
|
2016
Q1 | $2K | Buy |
+28
| New | +$1.76K | ﹤0.01% | 1389 |
|
|
2015
Q4 | – | Sell |
-1,359
| Closed | -$77K | – | 1758 |
|
|
2015
Q3 | $77K | Hold |
1,359
| – | – | 0.05% | 295 |
|
|
2015
Q2 | $72K | Buy |
+1,359
| New | +$66.1K | 0.05% | 337 |
|
Quadrant Capital Group's CMD Position: Q2 2021 in Review
Quadrant Capital Group sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3 shares.
Quadrant Capital Group first reported a position in CMD in Q2 2015 and held it in 23 quarters. The position peaked at $77K in Q3 2015. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Quadrant Capital Group reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Quadrant Capital Group sold 3 Cantel Medical Corporation shares in Q2 2021.
- Quadrant Capital Group first reported a position in Cantel Medical Corporation in Q2 2015 and held it in 23 quarters.
- Quadrant Capital Group's Cantel Medical Corporation position peaked at $77K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Quadrant Capital Group's 13F filing for Q2 2021, filed 9 Aug 2021.